Literature DB >> 19326078

Successful application of the dual-vector system II in creating a reliable phage-displayed combinatorial Fab library.

Suk-yoon Song1, Byung-ung Hur, Kyung-woo Lee, Hyo-jung Choi, Sung-soo Kim, Goo Kang, Sang-hoon Cha.   

Abstract

The dual-vector system-II (DVS-II), which allows efficient display of Fab antibodies on phage, has been reported previously, but its practical applicability in a phage-displayed antibody library has not been verified. To resolve this issue, we created two small combinatorial human Fab antibody libraries using the DVS-II, and isolation of target-specific antibodies was attempted. Biopanning of one antibody library, termed DVFAB-1L library, which has a 1.3 x 10(7) combinatorial antibody complexity, against fluorescein-BSA resulted in successful isolation of human Fab clones specific for the antigen despite the presence of only a single light chain in the library. By using the unique feature of the DVS-II, an antibody library of a larger size, named DVFAB-131L, which has a 1.5 x 10(9) combinatorial antibody complexity, was also generated in a rapid manner by combining 1.3 x 10(7) heavy chains and 131 light chains and more diverse anti-fluorescein-BSA Fab antibody clones were successfully obtained. Our results demonstrate that the DVS-II can be applied readily in creating phage-displayed antibody libraries with much less effort, and target-specific antibody clones can be isolated reliably via light chain promiscuity of antibody molecule.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326078     DOI: 10.1007/s10059-009-0040-0

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  1 in total

1.  Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen.

Authors:  Seung Kee Moon; So Ra Park; Ami Park; Hyun Mi Oh; Hyun Jung Shin; Eun Ju Jeon; Seiwhan Kim; Hyun June Park; Young Joo Yeon; Young Je Yoo
Journal:  Mol Cells       Date:  2016-01-07       Impact factor: 5.034

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.